You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日速報》恆指升380點; 恆生科技指數升127點 阿里巴巴升逾6% 美團升逾4% 港交所升逾3% 上美股份創新高
恆指半日收15,890點,升380點或2.5%。恆生科技指數報3,166點,升127點或4.2%。國指升161點或3.1%,報5,378點。 活躍重磅股表現: 阿里巴巴(09988.HK) 收75.45元,上升6.8%; 美團(03690.HK) 收68.25元,上升4.9%; 港交所(00388.HK) 收239.2元,上升3.7%; 平安(02318.HK) 收32.95元,上升3.3%; 騰訊(00700.HK) 收286元,上升2.3%; 建行(00939.HK) 收4.68元,上升1.5%; 友邦(01299.HK) 收61.05元,上升1.3%; 異動恆指及國指成份股: 吉利(00175.HK) 收8.15元,上升7%; 快手-W(01024.HK) 收42.8元,上升6.7%; 龍湖(00960.HK) 收8.9元,上升6.7%; 碧桂園服務(06098.HK) 收5.4元,上升6.3%; 蒙牛(02319.HK) 收18.26元,上升5.9%; 翰森製藥(03692.HK) 收12.28元,上升5.1%; 京東集團(09618.HK) 收90.4元,上升5.1%; 聯想集團(00992.HK) 收8.28元,上升4.9%; 海爾智家(06690.HK) 收23.35元,上升4.7%; 中芯(00981.HK) 收14.78元,上升4.7%; 舜宇(02382.HK) 收47.4元,上升4.6%; 藥明康德(02359.HK) 收47.55元,上升4.6%; 華潤啤酒(00291.HK) 收29.5元,上升4.6%; 石藥(01093.HK) 收6.01元,上升4.5%; 康師傅控股(00322.HK) 收7.97元,上升4.5%; 小米集團(01810.HK) 收12.66元,上升4.5%; 京東健康(06618.HK) 收27.4元,上升4.4%; 信義光能(00968.HK) 收3.61元,上升4.3%; 招行(03968.HK) 收28.95元,上升4.3%; 中生製藥(01177.HK) 收2.9元,上升4.3%; 比亞迪(01211.HK) 收178.5元,上升4%; 阿里健康(00241.HK) 收2.92元,上升3.9%; 國藥(01099.HK) 收21.35元,上升3.9%; 李寧(02331.HK) 收18.72元,上升3.9%; 商湯-W(00020.HK) 收0.81元,上升3.8%; 中信股份(00267.HK) 收7.62元,上升3.8%; 京東物流(02618.HK) 收7.08元,上升3.8%; 國壽(02628.HK) 收9.2元,上升3.7%; 華潤置地(01109.HK) 收24.05元,上升3.4%; 信義玻璃(00868.HK) 收6.39元,上升3.4%; 周大福(01929.HK) 收11元,上升3.4%; 理想汽車(02015.HK) 收114.6元,上升3.2%; 聯通(00762.HK) 收5.42元,上升3%; 異動綜合中小型股: 開拓藥業-B(09939.HK) 收1.85元,上升22.5%; 上美股份(02145.HK) 收36.1元,上升12.6%,創新高; 華晨中國(01114.HK) 收3.94元,下跌12.4%; 騰盛博藥-B(02137.HK) 收1.78元,上升10.6%; 樂普生物(02157.HK) 收3.28元,上升10.4%; 高視醫療(02407.HK) 收31.45元,下跌10.1%; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account